US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amylyx Pharmaceuticals

4.92

+0.690016.31%

Pre-market: 5.100.1800+3.66%08:03 EDT

Volume:1.94M

Turnover:9.23M

Market Cap:435.92M

PE:-1.11

High:4.95

Open:4.28

Low:4.28

Close:4.23

Loading ...

Overview Company News Filings

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Press Release: Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Amylyx Pharmaceuticals Inc expected to post a loss of 52 cents a share - Earnings Preview

Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study

MT Newswires Live

Amylyx Pharmaceuticals Inc - to Move Forward With Trial Sites Across North America

THOMSON REUTERS

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on Amx0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

THOMSON REUTERS

Amylyx Pharmaceuticals Inc - to Initiate Phase 1 Lumina Trial in Canada in Early 2025

THOMSON REUTERS

Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering

MT Newswires Live

BRIEF-Amylyx Pharmaceuticals Prices Public Offering Of Common Stock

Amylyx Pharmaceuticals Inc - Gross Proceeds Expected to Be Approximately $60 Million

THOMSON REUTERS

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

THOMSON REUTERS

Amylyx Pharmaceuticals Inc - Prices Public Offering of 17,142,857 Shares at $3.50 per Share

THOMSON REUTERS

Amylyx Pharmaceuticals Launches Stock Offering

MT Newswires Live

Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock

THOMSON REUTERS

Amylyx appoints Dan Monahan as Chief Commercial Officer

Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer

THOMSON REUTERS

Amylyx Pharmaceuticals, Gubra Collaborate on GLP-1 Therapy Development

MT Newswires Live

Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development

Gubra Announces Collaboration With Amylyx Pharmaceuticals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AMLX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AMLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","market":"US","secType":"STK","nameCN":"Amylyx Pharmaceuticals","latestPrice":4.92,"timestamp":1745352000000,"preClose":4.23,"halted":0,"volume":1938111,"hourTrading":{"tag":"盘前","latestPrice":5.1,"preClose":4.92,"latestTime":"08:03 EDT","volume":207,"amount":1015.549038,"timestamp":1745409839070},"delay":0,"floatShares":58959874,"shares":88602468,"eps":-4.43,"marketStatus":"Pre-Mkt","change":0.69,"latestTime":"04-23 08:16:30 EDT","open":4.28,"high":4.95,"low":4.28,"amount":9233098.784448,"amplitude":0.158392,"askPrice":5.24,"askSize":125,"bidPrice":4.51,"bidSize":600,"shortable":3,"etf":0,"ttmEps":-4.43,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1745415000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1641531600000,"exchange":"NASDAQ","adjPreClose":4.92,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":5.1,"preClose":4.92,"latestTime":"08:03 EDT","volume":207,"amount":1015.549038,"timestamp":1745409839070},"postHourTrading":{"tag":"盘后","latestPrice":4.9022,"preClose":4.92,"latestTime":"19:51 EDT","volume":6805,"amount":32972.7313,"timestamp":1745365869259},"volumeRatio":2.414554819979797,"impliedVol":0.7521,"impliedVolPercentile":0.3574},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AMLX\",,,,,undefined,":{"symbol":"AMLX","floatShares":58959874,"roa":"-51.31%","roe":"-100.88%","lyrEps":-4.428139,"volumeRatio":2.414554819979797,"shares":88602468,"dividePrice":1.35477,"high":4.95,"amplitude":0.158392,"preClose":4.23,"low":4.28,"week52Low":1.575,"pbRate":"2.65","psRate":"4.99","week52High":7.27,"institutionHeld":0,"latestPrice":4.92,"committee":0.655172,"eps":-4.43,"divideRate":0.27536,"volume":1938111,"delay":0,"ttmEps":-4.43,"open":4.28,"prevYearClose":3.78,"prevWeekClose":3.98,"prevMonthClose":3.54,"prevQuarterClose":3.54,"fiveDayClose":3.9,"twentyDayClose":3.78,"sixtyDayClose":3.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AMLX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514324626","title":"Amylyx Pharmaceuticals Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324626","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324626?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:42","pubTimestamp":1740750125,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc  expected to post a loss of52cents a share - Earnings Preview Amylyx Pharmaceuticals Inc AMLX.OQ AMLX.O is expected to show a fall in quarterly revenue when it reports  resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL5N3PJ1CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2513722928","title":"Press Release: Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2513722928","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513722928?lang=en_us&edition=fundamental","pubTime":"2025-02-24 22:22","pubTimestamp":1740406920,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals, Inc.   will report its fourth quarter and full year 2024 financial results on Tuesday, March 4, 2025. Amylyx' senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2513295326","title":"Amylyx Pharmaceuticals Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2513295326","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513295326?lang=en_us&edition=fundamental","pubTime":"2025-02-21 22:25","pubTimestamp":1740147909,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc  expected to post a loss of52cents a share - Earnings Preview Amylyx Pharmaceuticals Inc AMLX.OQ AMLX.O is expected to show a fall in quarterly revenue when it reports  resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250221:nL5N3PC1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2512934168","title":"Amylyx Pharmaceuticals Inc  expected to post a loss of 52 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2512934168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512934168?lang=en_us&edition=fundamental","pubTime":"2025-02-18 22:09","pubTimestamp":1739887767,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals Inc  expected to post a loss of52cents a share - Earnings Preview Amylyx Pharmaceuticals Inc AMLX.OQ AMLX.O is expected to show a fall in quarterly revenue when it reports  resu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250218:nL5N3P9193:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX"],"gpt_icon":0},{"id":"2505327609","title":"Amylyx Pharmaceuticals Says FDA Lifts Clinical Hold on Phase 1 ALS Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2505327609","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505327609?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:28","pubTimestamp":1737469737,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals  said Tuesday that the US Food and Drug Administration has lifted a clinical hold on a phase 1 clinical trial of AMX0114, an amyotrophic lateral sclerosis treatment candidate.The company said it is now in the process of opening US sites for screening, enrollment and dosing with the lifting of the clinical hold.Amylyx said the lifting of the clinical hold comes as it expects to start a phase 1 clinical trial in Canada that will assess the safety and biological activity of AMX0114, adding that it anticipates early group data from the study this year.Shares were down 5.2% ahead of Tuesday's opening bell.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2505427552","title":"Amylyx Pharmaceuticals Inc - to Move Forward With Trial Sites Across North America","url":"https://stock-news.laohu8.com/highlight/detail?id=2505427552","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505427552?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:00","pubTimestamp":1737468004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA5R5WVR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2505327554","title":"Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on Amx0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2505327554","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505327554?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:00","pubTimestamp":1737468004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA5R5WVR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2505275523","title":"Amylyx Pharmaceuticals Inc - to Initiate Phase 1 Lumina Trial in Canada in Early 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2505275523","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505275523?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:00","pubTimestamp":1737468004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nTUA5R5WVR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502861436","title":"Amylyx Pharmaceuticals Prices $60 Million Common Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2502861436","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502861436?lang=en_us&edition=fundamental","pubTime":"2025-01-10 22:10","pubTimestamp":1736518258,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals  said Friday it priced an underwritten offering of about 17.1 million common shares at $3.50 per share.The company also said it gave the underwriter a 30-day option to buy up to an additional 2.6 million shares at the offering price.Gross proceeds are expected to be about $60 million, excluding any exercise of the underwriter's overallotment option, the company said. The net proceeds from the offering, which is expected to close on or about Jan. 13, are expected to be used for working capital and for general corporate purposes and to help advance preparations for commercialization and pipeline programs.Shares of Amylyx were down 3.2% in recent premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502386913","title":"BRIEF-Amylyx Pharmaceuticals Prices Public Offering Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2502386913","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502386913?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:58","pubTimestamp":1736517491,"startTime":"0","endTime":"0","summary":"BRIEF-Amylyx Pharmaceuticals Prices Public Offering Of Common StockJan 10  - Amylyx Pharmaceuticals Inc AMLX.O:AMYLYX PHARMACEUTICALS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCKAMYLYX PHARMACEUTICALS INC - PRICES PUBLIC OFFERING OF 17,142,857 SHARES AT $3.50 PER SHAREAMYLYX PHARMACEUTICALS INC - GROSS PROCEEDS EXPECTED TO BE APPROXIMATELY $60 MILLIONSource text: nBw4yXTZLaFurther company coverage: AMLX.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4FDHQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502865658","title":"Amylyx Pharmaceuticals Inc - Gross Proceeds Expected to Be Approximately $60 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865658","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865658?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:26","pubTimestamp":1736515560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4FDHQJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502865655","title":"Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2502865655","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502865655?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:26","pubTimestamp":1736515560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4FDHQJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502656538","title":"Amylyx Pharmaceuticals Inc - Prices Public Offering of 17,142,857 Shares at $3.50 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2502656538","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502656538?lang=en_us&edition=fundamental","pubTime":"2025-01-10 21:26","pubTimestamp":1736515560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4FDHQJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502283292","title":"Amylyx Pharmaceuticals Launches Stock Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2502283292","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502283292?lang=en_us&edition=fundamental","pubTime":"2025-01-10 17:31","pubTimestamp":1736501479,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals  said late Thursday it has commenced an underwritten public offering of common shares.Amylyx plans to give the underwriter a 30-day option to buy up to an additional 15% of the shares offered.The company said the proceeds will be used to support commercialization, pipeline programs, working capital and general corporate needs.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2502342074","title":"Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2502342074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502342074?lang=en_us&edition=fundamental","pubTime":"2025-01-10 08:30","pubTimestamp":1736469000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250110:nTUA4NBMLR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2501823004","title":"Amylyx appoints Dan Monahan as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501823004","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501823004?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:20","pubTimestamp":1736173258,"startTime":"0","endTime":"0","summary":"Amylyx (AMLX) Pharmaceuticals announced the appointment of Dan Monahan as Chief Commercial Officer. Mr. Monahan will also join the Company’s Leader...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amylyx-appoints-dan-monahan-as-chief-commercial-officer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amylyx-appoints-dan-monahan-as-chief-commercial-officer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMLX","BK4007"],"gpt_icon":0},{"id":"2501232717","title":"Amylyx Pharmaceuticals Appoints Dan Monahan as Chief Commercial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2501232717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501232717?lang=en_us&edition=fundamental","pubTime":"2025-01-06 22:00","pubTimestamp":1736172004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250106:nTUAC0RNFN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","AMLX"],"gpt_icon":0},{"id":"2495657741","title":"Amylyx Pharmaceuticals, Gubra Collaborate on GLP-1 Therapy Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2495657741","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495657741?lang=en_us&edition=fundamental","pubTime":"2024-12-31 04:14","pubTimestamp":1735589643,"startTime":"0","endTime":"0","summary":"Amylyx Pharmaceuticals  said Monday it has entered into a collaborative research initiative with Gubra for long-acting GLP-1 therapies.The companies expect to select a lead candidate for investigational new drug-enabled development at the end of a screening period, Amylyx said in a US Securities and Exchange Commission filing.Under the collaboration, Amylyx said it will make a \"small\" upfront payment and research payments to Gubra, while Gubra is entitled to receive milestone payments of over $50 million and \"mid-single digit\" royalties on worldwide net sales.Amylyx said its payments are deemed immaterial to its financials, and that it continues to expect sufficient liquidity through 2026.Shares of Amylyx were down 1.7% in recent trading.Price: 3.81, Change: -0.07, Percent Change: -1.68","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4144","GLP","AMLX","BK4007","BK4590"],"gpt_icon":0},{"id":"2495457455","title":"Gubra and Amylyx team on novel long-acting GLP-1 receptor antagonist development","url":"https://stock-news.laohu8.com/highlight/detail?id=2495457455","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495457455?lang=en_us&edition=fundamental","pubTime":"2024-12-31 03:00","pubTimestamp":1735585238,"startTime":"0","endTime":"0","summary":"Gubra A/S announced a collaboration with Amylyx (AMLX) Pharmaceuticals for the development of a potential novel long-acting GLP-1 receptor antagoni...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gubra-and-amylyx-team-on-novel-long-acting-glp-1-receptor-antagonist-development?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gubra-and-amylyx-team-on-novel-long-acting-glp-1-receptor-antagonist-development?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4590","BK4007","BK4144","GLP","AMLX"],"gpt_icon":0},{"id":"2495549960","title":"Gubra Announces Collaboration With Amylyx Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2495549960","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495549960?lang=en_us&edition=fundamental","pubTime":"2024-12-30 20:45","pubTimestamp":1735562729,"startTime":"0","endTime":"0","summary":"Dec 30 (Reuters) - Gubra A/S ::*ANNOUNCES NEW COLLABORATION WITH AMYLYX PHARMACEUTICALS*COLLABORATION TO DEVELOP NOVEL LONG-ACTING GLP-1 RECEPTOR ANTAGONIST*WILL RECEIVE UPFRONT AND RESEARCH PAYMENTS*","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241230:nRSDYZLmk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMLX","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":65,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AMLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-04","symbol":"AMLX","fiscalQuarterEnding":"2024/12","expectedEps":-0.49,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1741064400000,"reportTimeType":"pre","actualEps":-0.55},{"market":"US","date":"2024-11-07","symbol":"AMLX","fiscalQuarterEnding":"2024/09","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.53},{"market":"US","date":"2024-08-08","symbol":"AMLX","fiscalQuarterEnding":"2024/06","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"pre","actualEps":-0.73},{"market":"US","date":"2024-05-09","symbol":"AMLX","fiscalQuarterEnding":"2024/03","expectedEps":0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.46},{"market":"US","date":"2024-02-22","symbol":"AMLX","fiscalQuarterEnding":"2023/12","expectedEps":0.2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"pre","actualEps":0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AMLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AMLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.3333,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":6,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AMLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AMLX","date":"2025-04-22","current":-1.242078,"percent":0.695381,"low":-27.24786,"twenty":-13.362502,"median":-9.00717,"eighty":-0.913571,"high":660.566108,"avg":39.506526,"sd":154.77466,"marketCap":374788439},"quantilePoints":[{"date":"2022-01-07","current":-14.965618,"twenty":-15.735846,"median":-15.735846,"eighty":-15.273709,"marketCap":1020340854},{"date":"2022-01-14","current":-17.069252,"twenty":-16.953304,"median":-16.183076,"eighty":-15.273709,"marketCap":1163764527},{"date":"2022-01-21","current":-15.338309,"twenty":-17.016247,"median":-16.328011,"eighty":-15.417816,"marketCap":1045750560},{"date":"2022-01-28","current":-16.564048,"twenty":-16.799258,"median":-16.025717,"eighty":-15.619898,"marketCap":1129320260},{"date":"2022-02-04","current":-18.651119,"twenty":-18.372842,"median":-16.597176,"eighty":-15.696092,"marketCap":1271614612},{"date":"2022-02-11","current":-15.942897,"twenty":-17.579425,"median":-16.564048,"eighty":-15.735846,"marketCap":1086970750},{"date":"2022-02-18","current":-21.939082,"twenty":-18.462288,"median":-16.667574,"eighty":-15.754066,"marketCap":1495784684},{"date":"2022-02-25","current":-25.657711,"twenty":-19.073502,"median":-16.791804,"eighty":-15.826948,"marketCap":1749317082},{"date":"2022-03-04","current":-22.684464,"twenty":-21.939082,"median":-17.052688,"eighty":-15.942897,"marketCap":1546604096},{"date":"2022-03-11","current":-21.541545,"twenty":-22.684464,"median":-17.512341,"eighty":-16.025717,"marketCap":1468680998},{"date":"2022-03-18","current":-18.841605,"twenty":-22.361465,"median":-18.560016,"eighty":-16.24105,"marketCap":1284601795},{"date":"2022-03-25","current":-20.705061,"twenty":-21.939082,"median":-18.237018,"eighty":-16.28246,"marketCap":1411650325},{"date":"2022-04-01","current":-8.475859,"twenty":-21.905954,"median":-17.624148,"eighty":-15.826948,"marketCap":745290715},{"date":"2022-04-08","current":-8.982567,"twenty":-21.541545,"median":-17.06097,"eighty":-15.603334,"marketCap":789846138},{"date":"2022-04-14","current":-7.771731,"twenty":-21.528294,"median":-16.965727,"eighty":-13.72994,"marketCap":683376036},{"date":"2022-04-22","current":-6.560894,"twenty":-20.869045,"median":-16.804227,"eighty":-9.310283,"marketCap":576905934},{"date":"2022-04-29","current":-5.922572,"twenty":-20.605676,"median":-16.667574,"eighty":-8.660117,"marketCap":520777674},{"date":"2022-05-06","current":-5.034186,"twenty":-19.593613,"median":-16.564048,"eighty":-7.877021,"marketCap":442661022},{"date":"2022-05-13","current":-4.079021,"twenty":-19.267301,"median":-16.261755,"eighty":-7.076815,"marketCap":494605759},{"date":"2022-05-20","current":-4.199702,"twenty":-19.20767,"median":-15.942897,"eighty":-6.639861,"marketCap":509239066},{"date":"2022-05-27","current":-4.23832,"twenty":-19.098348,"median":-15.735846,"eighty":-6.288455,"marketCap":513921724},{"date":"2022-06-03","current":-5.961646,"twenty":-19.02381,"median":-15.644744,"eighty":-5.98953,"marketCap":722885341},{"date":"2022-06-10","current":-6.531261,"twenty":-18.965835,"median":-14.965618,"eighty":-5.946016,"marketCap":791954547},{"date":"2022-06-17","current":-8.606975,"twenty":-18.884671,"median":-12.812292,"eighty":-5.98953,"marketCap":1043647419},{"date":"2022-06-24","current":-9.031773,"twenty":-18.838292,"median":-9.572716,"eighty":-6.047604,"marketCap":1095156658},{"date":"2022-07-01","current":-9.398643,"twenty":-18.760441,"median":-9.500016,"eighty":-6.16474,"marketCap":1139641910},{"date":"2022-07-08","current":-10.721308,"twenty":-18.632898,"median":-9.557942,"eighty":-6.256367,"marketCap":1300022949},{"date":"2022-07-15","current":-9.89585,"twenty":-18.528544,"median":-9.681037,"eighty":-6.279867,"marketCap":1199931133},{"date":"2022-07-22","current":-10.644072,"twenty":-18.336402,"median":-9.891022,"eighty":-6.326623,"marketCap":1290657633},{"date":"2022-07-29","current":-13.028731,"twenty":-18.053157,"median":-10.004462,"eighty":-6.460206,"marketCap":1579811769},{"date":"2022-08-05","current":-12.029491,"twenty":-17.90905,"median":-10.243411,"eighty":-6.531923,"marketCap":1458647991},{"date":"2022-08-12","current":-9.562145,"twenty":-17.579425,"median":-10.400296,"eighty":-6.536805,"marketCap":1466842643},{"date":"2022-08-19","current":-9.485831,"twenty":-17.334277,"median":-10.06963,"eighty":-6.548772,"marketCap":1455135998},{"date":"2022-08-26","current":-10.039108,"twenty":-17.065939,"median":-9.989202,"eighty":-6.580636,"marketCap":1540009176},{"date":"2022-09-02","current":-6.898786,"twenty":-17.03778,"median":-9.89585,"eighty":-6.660919,"marketCap":1058280726},{"date":"2022-09-09","current":-11.401313,"twenty":-16.97815,"median":-9.89585,"eighty":-6.659603,"marketCap":1748972792},{"date":"2022-09-16","current":-11.210528,"twenty":-16.953304,"median":-9.989202,"eighty":-6.666184,"marketCap":1719706179},{"date":"2022-09-23","current":-10.634357,"twenty":-16.878765,"median":-10.096343,"eighty":-6.830104,"marketCap":1631321008},{"date":"2022-09-30","current":-10.741197,"twenty":-16.804227,"median":-10.278624,"eighty":-6.898786,"marketCap":1647710311},{"date":"2022-10-07","current":-13.802176,"twenty":-16.779381,"median":-10.619936,"eighty":-6.916248,"marketCap":2117267640},{"date":"2022-10-14","current":-14.91268,"twenty":-16.704843,"median":-10.68269,"eighty":-6.955732,"marketCap":2287620052},{"date":"2022-10-21","current":-15.663927,"twenty":-16.630305,"median":-10.741197,"eighty":-7.071912,"marketCap":2402862058},{"date":"2022-10-28","current":-15.698467,"twenty":-16.564048,"median":-10.820266,"eighty":-7.107086,"marketCap":2408160541},{"date":"2022-11-04","current":-14.839283,"twenty":-16.564048,"median":-11.050268,"eighty":-7.166312,"marketCap":2276360776},{"date":"2022-11-11","current":-12.241999,"twenty":-16.414972,"median":-11.147569,"eighty":-7.617391,"marketCap":2252711412},{"date":"2022-11-18","current":-12.598457,"twenty":-16.350411,"median":-11.290658,"eighty":-7.771731,"marketCap":2318305067},{"date":"2022-11-25","current":-13.952278,"twenty":-16.29605,"median":-11.35934,"eighty":-7.771731,"marketCap":2567428447},{"date":"2022-12-02","current":-14.125106,"twenty":-16.249332,"median":-11.460456,"eighty":-7.806593,"marketCap":2599231432},{"date":"2022-12-09","current":-12.836096,"twenty":-16.1662,"median":-11.775251,"eighty":-7.885736,"marketCap":2362034171},{"date":"2022-12-16","current":-12.843297,"twenty":-16.050071,"median":-11.935471,"eighty":-8.033728,"marketCap":2363359296},{"date":"2022-12-23","current":-12.803691,"twenty":-15.960795,"median":-12.029491,"eighty":-8.236016,"marketCap":2356071112},{"date":"2022-12-30","current":-13.304172,"twenty":-15.943564,"median":-12.241999,"eighty":-8.385046,"marketCap":2448167255},{"date":"2023-01-06","current":-13.318575,"twenty":-15.896517,"median":-12.362571,"eighty":-8.462395,"marketCap":2450817503},{"date":"2023-01-13","current":-13.498604,"twenty":-15.790507,"median":-12.391845,"eighty":-8.473431,"marketCap":2483945612},{"date":"2023-01-20","current":-13.275368,"twenty":-15.735846,"median":-12.443631,"eighty":-8.502082,"marketCap":2442866757},{"date":"2023-01-27","current":-14.737206,"twenty":-15.72837,"median":-12.465235,"eighty":-8.626816,"marketCap":2711867002},{"date":"2023-02-03","current":-13.192554,"twenty":-15.696004,"median":-12.546391,"eighty":-8.713372,"marketCap":2427627827},{"date":"2023-02-10","current":-12.278005,"twenty":-15.681709,"median":-12.523129,"eighty":-8.748896,"marketCap":2259337033},{"date":"2023-02-17","current":-13.368983,"twenty":-15.658746,"median":-12.575053,"eighty":-8.817175,"marketCap":2460093374},{"date":"2023-02-24","current":-12.425629,"twenty":-15.638022,"median":-12.582254,"eighty":-8.982159,"marketCap":2286502083},{"date":"2023-03-03","current":-12.321212,"twenty":-15.603334,"median":-12.537247,"eighty":-8.982567,"marketCap":2267287779},{"date":"2023-03-10","current":-11.039402,"twenty":-15.534402,"median":-12.530188,"eighty":-9.031773,"marketCap":2031415643},{"date":"2023-03-17","current":-10.186966,"twenty":-15.504179,"median":-12.49404,"eighty":-9.054954,"marketCap":2020839392},{"date":"2023-03-24","current":-9.665679,"twenty":-15.486909,"median":-12.456774,"eighty":-9.147083,"marketCap":1917428991},{"date":"2023-03-31","current":-9.867467,"twenty":-15.435099,"median":-12.43283,"eighty":-9.169128,"marketCap":1957458823},{"date":"2023-04-06","current":-9.352906,"twenty":-15.421283,"median":-12.415671,"eighty":-9.271642,"marketCap":1855382750},{"date":"2023-04-14","current":-10.284497,"twenty":-15.404013,"median":-12.363817,"eighty":-9.314874,"marketCap":2040187145},{"date":"2023-04-21","current":-10.371939,"twenty":-15.352203,"median":-12.317611,"eighty":-9.344721,"marketCap":2057533405},{"date":"2023-04-28","current":-9.540583,"twenty":-15.33867,"median":-12.281606,"eighty":-9.352541,"marketCap":1892613220},{"date":"2023-05-05","current":-9.381574,"twenty":-15.156691,"median":-12.115978,"eighty":-9.37584,"marketCap":1861069667},{"date":"2023-05-12","current":-12.985377,"twenty":-14.994752,"median":-12.108777,"eighty":-9.395229,"marketCap":1934223866},{"date":"2023-05-19","current":-12.108956,"twenty":-14.947446,"median":-12.115978,"eighty":-9.401237,"marketCap":1803677398},{"date":"2023-05-26","current":-11.860914,"twenty":-14.918725,"median":-12.116976,"eighty":-9.404582,"marketCap":1766730562},{"date":"2023-06-02","current":-11.026591,"twenty":-14.881594,"median":-12.108866,"eighty":-9.409977,"marketCap":1642454838},{"date":"2023-06-09","current":-11.838365,"twenty":-14.847918,"median":-12.041308,"eighty":-9.445302,"marketCap":1763371758},{"date":"2023-06-16","current":-11.166396,"twenty":-14.778037,"median":-12.006124,"eighty":-9.4782,"marketCap":1663279418},{"date":"2023-06-23","current":-11.175416,"twenty":-14.689959,"median":-11.960384,"eighty":-9.490139,"marketCap":1664622940},{"date":"2023-06-30","current":-9.461672,"twenty":-14.615348,"median":-11.875318,"eighty":-9.487985,"marketCap":1409353885},{"date":"2023-07-07","current":-9.276768,"twenty":-14.600384,"median":-11.818255,"eighty":-9.461672,"marketCap":1381811698},{"date":"2023-07-14","current":-10.372662,"twenty":-14.560777,"median":-11.775251,"eighty":-9.461672,"marketCap":1545049541},{"date":"2023-07-21","current":-10.106581,"twenty":-14.525026,"median":-11.523392,"eighty":-9.466753,"marketCap":1505415661},{"date":"2023-07-28","current":-10.038933,"twenty":-14.511152,"median":-11.468324,"eighty":-9.484221,"marketCap":1495339251},{"date":"2023-08-04","current":-10.169719,"twenty":-14.445559,"median":-11.399203,"eighty":-9.485831,"marketCap":1514820310},{"date":"2023-08-11","current":-19.589727,"twenty":-14.445559,"median":-11.396399,"eighty":-9.496602,"marketCap":1426386819},{"date":"2023-08-18","current":-18.701388,"twenty":-14.600384,"median":-11.401111,"eighty":-9.500016,"marketCap":1361704186},{"date":"2023-08-25","current":-20.107925,"twenty":-14.86087,"median":-11.504635,"eighty":-9.535435,"marketCap":1464118355},{"date":"2023-09-01","current":-19.950615,"twenty":-15.111286,"median":-11.536747,"eighty":-9.540583,"marketCap":1452664139},{"date":"2023-09-08","current":-19.321375,"twenty":-15.404013,"median":-11.782004,"eighty":-9.55447,"marketCap":1406847273},{"date":"2023-09-15","current":-18.146176,"twenty":-15.510224,"median":-11.838365,"eighty":-9.561304,"marketCap":1321277540},{"date":"2023-09-22","current":-16.730386,"twenty":-15.668372,"median":-11.914636,"eighty":-9.580399,"marketCap":1218189593},{"date":"2023-09-29","current":-17.119034,"twenty":-15.754066,"median":-11.982756,"eighty":-9.586985,"marketCap":1246488245},{"date":"2023-10-06","current":-16.443526,"twenty":-16.050071,"median":-12.0354,"eighty":-9.604096,"marketCap":1197302493},{"date":"2023-10-13","current":-16.29547,"twenty":-16.249332,"median":-12.108777,"eighty":-9.611049,"marketCap":1186522054},{"date":"2023-10-20","current":-15.314596,"twenty":-16.285062,"median":-12.116976,"eighty":-9.618907,"marketCap":1115101646},{"date":"2023-10-27","current":-14.759384,"twenty":-16.274178,"median":-12.163074,"eighty":-9.620949,"marketCap":1074675000},{"date":"2023-11-03","current":-16.674865,"twenty":-16.274178,"median":-12.257781,"eighty":-9.623732,"marketCap":1214146928},{"date":"2023-11-10","current":450.85384,"twenty":-16.339423,"median":-12.267893,"eighty":-9.620949,"marketCap":827767651},{"date":"2023-11-17","current":446.073172,"twenty":-16.292868,"median":-12.208173,"eighty":-9.585468,"marketCap":818990343},{"date":"2023-11-24","current":484.318522,"twenty":-16.28246,"median":-12.115978,"eighty":-9.540583,"marketCap":889208807},{"date":"2023-12-01","current":520.725154,"twenty":-16.24105,"median":-12.108777,"eighty":-9.485831,"marketCap":956051382},{"date":"2023-12-08","current":522.931616,"twenty":-16.175174,"median":-12.029491,"eighty":-9.457162,"marketCap":960102447},{"date":"2023-12-15","current":542.054291,"twenty":-16.147488,"median":-11.981987,"eighty":-9.401886,"marketCap":995211679},{"date":"2023-12-22","current":513.002535,"twenty":-16.036371,"median":-11.889723,"eighty":-9.351083,"marketCap":941872654},{"date":"2023-12-29","current":542.422035,"twenty":-16.030819,"median":-11.849639,"eighty":-9.28907,"marketCap":995886856},{"date":"2024-01-05","current":611.925604,"twenty":-16.026838,"median":-11.798146,"eighty":-9.172617,"marketCap":1123495409},{"date":"2024-01-12","current":596.480367,"twenty":-16.009487,"median":-11.66078,"eighty":-8.992408,"marketCap":1095137953},{"date":"2024-01-19","current":547.202704,"twenty":-15.944565,"median":-11.523392,"eighty":-8.742138,"marketCap":1004664164},{"date":"2024-01-26","current":565.222148,"twenty":-15.942897,"median":-11.468324,"eighty":-8.471813,"marketCap":1037747863},{"date":"2024-02-02","current":609.351398,"twenty":-15.826948,"median":-11.399203,"eighty":-7.903343,"marketCap":1118769167},{"date":"2024-02-09","current":568.531842,"twenty":-15.82354,"median":-11.35934,"eighty":-7.617391,"marketCap":1043824461},{"date":"2024-02-16","current":565.589892,"twenty":-15.749512,"median":-11.333465,"eighty":-6.955732,"marketCap":1038423041},{"date":"2024-02-23","current":25.505487,"twenty":-15.738579,"median":-11.295413,"eighty":-6.79732,"marketCap":1256680857},{"date":"2024-03-01","current":25.931954,"twenty":-15.735846,"median":-11.210528,"eighty":-6.545379,"marketCap":1277693320},{"date":"2024-03-08","current":26.097038,"twenty":-15.705943,"median":-11.186691,"eighty":-6.413487,"marketCap":1285827176},{"date":"2024-03-15","current":4.360971,"twenty":-15.688617,"median":-11.153292,"eighty":-6.087088,"marketCap":214869380},{"date":"2024-03-22","current":3.94826,"twenty":-15.668372,"median":-11.128797,"eighty":-5.859309,"marketCap":194534738},{"date":"2024-03-28","current":3.962017,"twenty":-15.648384,"median":-11.044835,"eighty":-4.906998,"marketCap":195212560},{"date":"2024-04-05","current":3.590578,"twenty":-15.617209,"median":-11.017571,"eighty":-4.329072,"marketCap":176911382},{"date":"2024-04-12","current":3.150354,"twenty":-15.591102,"median":-10.839424,"eighty":-4.211287,"marketCap":155221098},{"date":"2024-04-19","current":2.723887,"twenty":-15.55382,"median":-10.788969,"eighty":-4.079021,"marketCap":134208635},{"date":"2024-04-26","current":2.456825,"twenty":-15.516268,"median":-10.74692,"eighty":-3.715047,"marketCap":121050233},{"date":"2024-05-03","current":2.760478,"twenty":-15.493817,"median":-10.721308,"eighty":2.527963,"marketCap":136011498},{"date":"2024-05-10","current":-1.807875,"twenty":-15.455823,"median":-10.639214,"eighty":2.639017,"marketCap":128530865},{"date":"2024-05-17","current":-1.750482,"twenty":-15.424737,"median":-10.575606,"eighty":2.605891,"marketCap":124450520},{"date":"2024-05-24","current":-1.702655,"twenty":-15.407467,"median":-10.55061,"eighty":2.581476,"marketCap":121050233},{"date":"2024-05-31","current":-1.607,"twenty":-15.376381,"median":-10.462744,"eighty":2.542829,"marketCap":114249658},{"date":"2024-06-07","current":-1.683524,"twenty":-15.339392,"median":-10.375302,"eighty":2.481669,"marketCap":119690118},{"date":"2024-06-14","current":-1.607,"twenty":-15.333566,"median":-10.371939,"eighty":2.451304,"marketCap":114249658},{"date":"2024-06-21","current":-1.578303,"twenty":-15.314596,"median":-10.345603,"eighty":2.42922,"marketCap":112209485},{"date":"2024-06-28","current":-1.846137,"twenty":-15.233272,"median":-10.336583,"eighty":0.837689,"marketCap":131251095},{"date":"2024-07-05","current":-1.693089,"twenty":-15.107531,"median":-10.295995,"eighty":-1.553433,"marketCap":120370175},{"date":"2024-07-12","current":-2.180928,"twenty":-15.067132,"median":-10.277956,"eighty":-1.570651,"marketCap":155053107},{"date":"2024-07-15","current":-2.066143,"twenty":-15.041754,"median":-10.273446,"eighty":-1.572564,"marketCap":146892417},{"date":"2024-08-02","current":-1.980053,"twenty":-15.016375,"median":-10.2672,"eighty":-1.574477,"marketCap":140771900},{"date":"2024-08-09","current":-0.738827,"twenty":-14.951989,"median":-10.237413,"eighty":-1.574477,"marketCap":122548442},{"date":"2024-08-16","current":-0.886592,"twenty":-14.924769,"median":-10.186966,"eighty":-0.851292,"marketCap":147058130},{"date":"2024-08-23","current":-0.91122,"twenty":-14.881594,"median":-10.176877,"eighty":-0.87551,"marketCap":151143078},{"date":"2024-08-30","current":-0.870174,"twenty":-14.847918,"median":-10.167464,"eighty":-0.872636,"marketCap":144334832},{"date":"2024-09-06","current":-0.90301,"twenty":-14.807323,"median":-10.14717,"eighty":-0.871816,"marketCap":149781429},{"date":"2024-09-13","current":-1.022044,"twenty":-14.750513,"median":-10.111091,"eighty":-0.874278,"marketCap":169525345},{"date":"2024-09-20","current":-1.182123,"twenty":-14.689959,"median":-10.097576,"eighty":-0.875099,"marketCap":196077507},{"date":"2024-09-27","current":-1.31347,"twenty":-14.611607,"median":-10.070502,"eighty":-0.880435,"marketCap":217863897},{"date":"2024-10-04","current":-1.20675,"twenty":-14.591806,"median":-10.05255,"eighty":-0.886592,"marketCap":200162455},{"date":"2024-10-11","current":-1.420189,"twenty":-14.573388,"median":-9.984815,"eighty":-0.893159,"marketCap":235565339},{"date":"2024-10-18","current":-1.609,"twenty":-14.563346,"median":-9.930486,"eighty":-0.90301,"marketCap":266883274},{"date":"2024-10-25","current":-2.01125,"twenty":-14.546477,"median":-9.907825,"eighty":-0.904652,"marketCap":333604093},{"date":"2024-10-31","current":-2.16312,"twenty":-14.522251,"median":-9.891022,"eighty":-0.907936,"marketCap":358794606},{"date":"2024-11-08","current":-1.71606,"twenty":-14.498033,"median":-9.867467,"eighty":-0.91122,"marketCap":445259340},{"date":"2024-11-15","current":-1.317221,"twenty":-14.412048,"median":-9.847288,"eighty":-0.912041,"marketCap":341773989},{"date":"2024-11-22","current":-1.361828,"twenty":-14.258948,"median":-9.820895,"eighty":-0.917787,"marketCap":353348008},{"date":"2024-11-29","current":-1.453666,"twenty":-14.182716,"median":-9.792708,"eighty":-0.927638,"marketCap":377176872},{"date":"2024-12-06","current":-1.304101,"twenty":-14.161433,"median":-9.786381,"eighty":-0.927638,"marketCap":338369865},{"date":"2024-12-13","current":-1.15716,"twenty":-14.135908,"median":-9.753975,"eighty":-0.972788,"marketCap":300243683},{"date":"2024-12-20","current":-1.039082,"twenty":-14.125106,"median":-9.730036,"eighty":-1.022044,"marketCap":269606573},{"date":"2024-12-27","current":-1.067946,"twenty":-14.113584,"median":-9.665679,"eighty":-1.031477,"marketCap":277095644},{"date":"2025-01-03","current":-1.025963,"twenty":-14.015648,"median":-9.642275,"eighty":-1.012318,"marketCap":266202449},{"date":"2025-01-10","current":-0.989228,"twenty":-13.942196,"median":-9.632047,"eighty":-1.007595,"marketCap":256670904},{"date":"2025-01-17","current":-0.918381,"twenty":-13.90403,"median":-9.621327,"eighty":-0.945698,"marketCap":238288638},{"date":"2025-01-24","current":-0.934125,"twenty":-13.865081,"median":-9.609998,"eighty":-0.927638,"marketCap":242373586},{"date":"2025-01-31","current":-0.921005,"twenty":-13.841127,"median":-9.584963,"eighty":-0.918381,"marketCap":238969462},{"date":"2025-02-07","current":-0.98398,"twenty":-13.8128,"median":-9.549263,"eighty":-0.918381,"marketCap":255309255},{"date":"2025-02-14","current":-0.941996,"twenty":-13.770986,"median":-9.500016,"eighty":-0.918381,"marketCap":244416060},{"date":"2025-02-21","current":-0.923629,"twenty":-13.646228,"median":-9.485831,"eighty":-0.918381,"marketCap":239650287},{"date":"2025-02-28","current":-0.829167,"twenty":-13.53821,"median":-9.464213,"eighty":-0.913133,"marketCap":215140598},{"date":"2025-03-07","current":-0.814527,"twenty":-13.520208,"median":-9.457162,"eighty":-0.907115,"marketCap":245777709},{"date":"2025-03-14","current":-1.077642,"twenty":-13.509406,"median":-9.403571,"eighty":-0.905261,"marketCap":325171057},{"date":"2025-03-21","current":-1.095261,"twenty":-13.498604,"median":-9.381574,"eighty":-0.907115,"marketCap":330487205},{"date":"2025-03-28","current":-1.13637,"twenty":-13.4734,"median":-9.335179,"eighty":-0.907885,"marketCap":342891551},{"date":"2025-04-04","current":-1.030661,"twenty":-13.401388,"median":-9.276768,"eighty":-0.91122,"marketCap":310994662},{"date":"2025-04-11","current":-1.024788,"twenty":-13.390586,"median":-9.158106,"eighty":-0.91122,"marketCap":309222613},{"date":"2025-04-17","current":-1.121688,"twenty":-13.373304,"median":-9.043363,"eighty":-0.91275,"marketCap":338461427},{"date":"2025-04-22","current":-1.242078,"twenty":-13.362502,"median":-9.00717,"eighty":-0.913571,"marketCap":374788439}],"updateTime":1745410590718}}}